We only have this paper's title and publication details.
Read it at the sourceCaptured external expert commentary on this paper, strongest first. Original sources are linked where available.
“LATE-MT and MILD-MT [are] 'important advances' in a field that has sought to expand its range since the landmark thrombectomy trials in 2015. Still, the net benefit-risk ratio in the treatment of acute LVO appears to favor endovascular therapy. This finding was consistent with observational data showing that, despite the mild initial severity, acute LVO with minor symptoms is not a benign condition.”
No takes yet. Share an insight, caveat, or question.
Gaultier Marnat (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: